Insider · CIK 0001953943

Halladay Benjamin

Reports to the SEC for 2 companies · BOTHELL, WA

sec.gov

Transactions

Companies

Filings

CIK

0001953943

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-05	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2026-10-05	ACHVACHIEVE LIFE SCIENCES, INC. · Restricted Stock Unit (RSU)A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2026-07-13	ESPREsperion Therapeutics, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−705K sh	—	—	0
2026-07-13	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−200K sh	—	—	0
2026-07-13	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−213K sh	—	—	0
2026-07-13	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−221K sh	—	—	0
2026-06-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−10.8K sh	$3.15	−$34K	702,829
2026-03-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−6,424 sh	$2.71	−$17.4K	713,602
2026-03-13	ESPREsperion Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+247K sh	—	—	720,026
2026-03-13	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+221K sh	—	—	221,270
2025-12-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−7,337 sh	$3.67	−$26.9K	467,525
2025-09-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−7,046 sh	$2.81	−$19.8K	474,862
2025-07-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−11 sh	$1.11	−$12.265	474,462
2025-06-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−7,229 sh	$1.15	−$8,327.808	474,473
2025-04-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−8 sh	$0.96	−$7.712	481,702
2025-03-18	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−3,535 sh	$1.48	−$5,242.405	481,710
2025-03-14	ESPREsperion Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+238K sh	—	—	485,245
2025-03-14	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+213K sh	—	—	213,000
2025-02-19	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−11 sh	$1.86	−$20.46	240,671
2025-01-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−9 sh	$2.27	−$20.385	240,682
2024-12-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−3,245 sh	$2.42	−$7,865.88	240,691
2024-03-14	ESPREsperion Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+170K sh	—	—	243,936
2024-03-14	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2023-03-14	ESPREsperion Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+9,200 sh	—	—	73,936
2023-03-14	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+39K sh	—	—	39,000
2022-12-09	ESPREsperion Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+44K sh	—	—	63,771
2022-12-09	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+66K sh	—	—	66,000

Recent filings

Accepted (ET)
Oct 64
Halladay Benjamin0001953943-26-000004
SEC(opens sec.gov)
Jul 134
Halladay Benjamin0001628280-26-048000
SEC(opens sec.gov)
Jun 184
Halladay Benjamin0001628280-26-044264
SEC(opens sec.gov)
Mar 184
Halladay Benjamin0001628280-26-019409
SEC(opens sec.gov)
Mar 164
Halladay Benjamin0001628280-26-018186
SEC(opens sec.gov)
Dec 184
Halladay Benjamin0001628280-25-057942
SEC(opens sec.gov)
Sep 184
Halladay Benjamin0001953943-25-000004
SEC(opens sec.gov)
Jul 184
Halladay Benjamin0001628280-25-035334
SEC(opens sec.gov)
Jun 184
Halladay Benjamin0001628280-25-032217
SEC(opens sec.gov)
Apr 214
Halladay Benjamin0001628280-25-018566
SEC(opens sec.gov)
Mar 194
Halladay Benjamin0001628280-25-013812
SEC(opens sec.gov)
Mar 174
Halladay Benjamin0001628280-25-013198
SEC(opens sec.gov)
Feb 204
Halladay Benjamin0001628280-25-006801
SEC(opens sec.gov)
Jan 214
Halladay Benjamin0001628280-25-002037
SEC(opens sec.gov)

Companies

Address

C/O ACHIEVE LIFE SCIENCES, INC. 22722 29TH DR. SE, SUITE 100

BOTHELL, WA, 98021